Stock ABLD ABL DIAGNOSTICS
Add to a list
To use this feature you must be a member
Log inSign up

ABL Diagnostics Stock

Equities

ABLD

FR001400AHX6

Business Support Services

Real-time Euronext Paris
Other stock markets
 10:30:17 2024-04-25 am EDT 		5-day change 1st Jan Change
2.9 EUR 0.00% Intraday chart for ABL Diagnostics -8.81% -70.10%
2023 ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Financials

Sales 2021 18 19.29 Sales 2022 9.36M 10.03M Capitalization 29M 31.07M
Net income 2021 - 0 Net income 2022 1M 1.07M EV / Sales 2021 71,425 x
Net cash position 2021 2.7M 2.9M Net Debt 2022 1.64M 1.76M EV / Sales 2022 3.27 x
P/E ratio 2021
15.5 x
P/E ratio 2022
206 x
Employees 21
Yield 2021 *
-
Yield 2022
-
Free-Float 0.36%
More Fundamentals * Assessed data

Chart ABL Diagnostics

Dynamic Chart

Latest news about ABL Diagnostics

ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Roche, ABL Diagnostics Sign Distribution Partnership in South Africa MT
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Advanced Biological Laboratories S.A. completed the acquisition of a 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons. CI
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Advanced Biological Laboratories S.A. agreed to acquire the remaining 3.3% stake in Fauvet-Girel for €0.13 million. CI
Advanced Biological Laboratories S.A. acquired 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons for €3.9 million. CI
Advanced Biological Laboratories S.A. acquired 96.7% stake in Fauvet-Girel from STE Parisienne De Construction Et De Location and seven natural persons for €3.9 million. CI
Fauvet-Girel Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Bernard Krief Consultants SA completed the acquisition of 96.7% stake in Fauvet-Girel from Spaclo SA and members of the founding family. CI
Bernard Krief Consultants SA signed an agreement to acquire 96.7% stake in Fauvet-Girel from Spaclo SA and members of the founding family for €8.1 million. CI
Fauvet-Girel(ENXTPA:FAUV) dropped from CAC All-Tradable Index CI
Fauvet-Girel(ENXTPA:FAUV) dropped from CAC Small Index CI
More news

Press releases ABL Diagnostics

AdvancedDx Biological Laboratories USA Inc. and Medline Industries, LP to distribute Next Generation Sequencing (NGS) Prep Kits in the U.S. AQ
AdvancedDx Biological Laboratories USA Inc. expands its logistics and storage capacity for supporting and managing third-parties' clinical trials in the USA AQ
ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain. AQ
Block trading of ABL Diagnostics ordinary shares (ABLD, Euronext, compartment B) AQ
Carrying Out Research About HIV Whole Genome using a Kit Now Available in the USA AQ
More press releases

News in other languages on ABL Diagnostics

ABL DIAGNOSTICS : MISE EN PLACE D’UN CONTRAT DE LIQUIDITE AVEC ALLINVEST SECURITIES
ABL Diagnostics : Document AMF CP. 2023DD925593
ABL Diagnostics : Document AMF CP. 222C1869
Etablissements Fauvet Girel S A : Modalités de mise à disposition des documents préparatoires à l'AG
Etablissements Fauvet Girel S A : Informations privilégiées / Communiqué sur comptes, résultats
More news

Quotes and Performance

1 week-8.81%
Current month-8.81%
1 month-8.81%
3 months-70.10%
6 months-70.10%
Current year-70.10%
More quotes

Highs and lows

1 week
2.90
Extreme 2.9
3.18
1 month
2.90
Extreme 2.9
3.18
Current year
2.90
Extreme 2.9
9.70
1 year
2.90
Extreme 2.9
9.70
3 years
1.46
Extreme 1.4625
26.00
5 years
1.28
Extreme 1.275
26.00
10 years
1.28
Extreme 1.275
26.00
More quotes

Managers and Directors - ABL Diagnostics

Managers TitleAgeSince
Ronan Boulme CEO
 Chief Executive Officer - -
Members of the board TitleAgeSince
Jean-Christophe Renondin BRD
 Director/Board Member - -
Laure Raffaelli BRD
 Director/Board Member - -
Noemie Sadoun CHM
 Chairman - -
More insiders

Quotes

Date Price Change Volume
24-04-25 2.9 0.00% 199
24-04-24 2.9 -8.81% 299
24-04-23 3.18 0.00% 0
24-04-22 3.18 0.00% 0
24-04-19 3.18 0.00% 0

Real-time Euronext Paris, April 25, 2024 at 10:30 am EDT

More quotes

Company Profile

ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.3% of net sales.
Sector
Business Support Services
More about the company

Income Statement Evolution

More financial data

Sector Commercial Equipment Rental

1st Jan change Capi.
ABL DIAGNOSTICS Stock ABL Diagnostics
-70.10% 49.94M
UNITED RENTALS, INC. Stock United Rentals, Inc.
+17.54% 44.01B
ASHTEAD GROUP PLC Stock Ashtead Group plc
+5.38% 31.11B
WILLSCOT MOBILE MINI HOLDINGS CORP. Stock WillScot Mobile Mini Holdings Corp.
-15.15% 7.28B
AIR LEASE CORPORATION Stock Air Lease Corporation
+21.71% 5.72B
HERC HOLDINGS INC. Stock Herc Holdings Inc.
+2.22% 4.36B
AVIC INDUSTRY-FINANCE HOLDINGS CO., LTD. Stock AVIC Industry-Finance Holdings Co., Ltd.
-5.79% 3.62B
MCGRATH RENTCORP Stock McGrath RentCorp
-8.89% 2.66B
H&E EQUIPMENT SERVICES, INC. Stock H&E Equipment Services, Inc.
+9.67% 2.14B
BOHAI LEASING CO., LTD. Stock Bohai Leasing Co., Ltd.
+14.95% 2.1B
Commercial Equipment Rental
  1. Stock Market
  2. Equities
  3. ABLD Stock